First-in-human dose-escalation study of VCN-01, a selective oncolytic adenovirus with hyaluronidase activity in patients with advanced or metastatic cancer

Hidalgo, M ; Gil, M ; Garcia-Carbonero, R ; Alvarez, R ; Laquente, B ; Moreno, R ; De Martino, A ; Alemany, R ; Capella, G ; Blasi, E ; Viaplana, I ; Cascallo, M ; Salazar, R

European journal of cancer (1990), 2016-12, Vol.69, p.S99-S100 [Periódico revisado por pares]

Oxford: Elsevier Science Ltd

Texto completo disponível